国瑞健康(02329) - 2024 - 年度业绩

Announcement Overview This supplementary announcement from Guorui Health Industry Co., Ltd. updates on the auditor's disclaimer of opinion for its 2024 annual report Purpose and Background of Announcement Guorui Health Industry Co., Ltd. issues this supplementary announcement to provide further updates on the auditor's disclaimer of opinion for its 2024 annual report - This is a supplementary announcement issued by Guorui Health Industry Co., Ltd. (Stock Code: 2329)[2] - The announcement concerns the annual report for the year ended December 31, 2024, aiming to provide further updates on the auditor's disclaimer of opinion[2][3] Auditor's Disclaimer of Opinion The auditor issued a disclaimer of opinion on the Group's 2024 financial statements, citing significant uncertainties about its going concern ability Disclaimer of Opinion Disclosure The auditor issued a disclaimer of opinion on the Group's consolidated financial statements for the year ended December 31, 2024, due to significant uncertainties that may cast substantial doubt on its ability to continue as a going concern - The auditor issued a disclaimer of opinion on the Group's consolidated financial statements for the year ended December 31, 2024[3] - The disclaimer is due to significant uncertainties that may cast substantial doubt on the Group's ability to continue as a going concern[3] - This implies the Group may be unable to realize its assets and discharge its liabilities in the normal course of business[3] Company's Response and Progress The company is actively implementing measures, including debt restructuring and asset disposals, to address the auditor's disclaimer of opinion and resolve going concern issues Debt Restructuring Progress The company addresses the auditor's disclaimer by extending a RMB 1.314 billion Tianjin Bank loan and negotiating other debt restructuring - The company has taken measures to address the disclaimer of opinion since April 30, 2025, in accordance with the action plan on page 39 of the annual report[4] Key Debt Restructuring Progress | Item | Status | Amount/Description | Deadline | | :--- | :--- | :--- | :--- | | Tianjin Bank Loan | Extension agreed | RMB 1.314 billion | June 30, 2025 | | Other financial institution loans and financing | Restructuring negotiations ongoing | - | - | Asset Disposal Plans The Group plans to sell commercial assets and transfer projects like Shenyang Company and Foshan Shengpingli to generate crucial cash flow - The Group is negotiating the sale of several self-held commercial assets to obtain cash[7] - Plans to transfer entire projects, including Shenyang Company and Foshan Shengpingli Project[7] - Plans to sell Beijing Beiwulou Property[7] Land Return Applications The company applied for land returns for the Shenyang and Chongming Island projects, awaiting government approval for undetermined land return funds - The Group has applied to the government for land returns for the Shenyang Project and Chongming Island Project[7] - Currently awaiting government approval; if approved, land return funds will be received[7] - The amount of land return funds depends on the final government approval[7] Management Outlook and Subsequent Reporting Management targets H2 2025 for debt restructuring and asset disposals to resolve going concern issues, with quarterly updates until the disclaimer is resolved - Management plans to complete debt restructuring and asset disposals as soon as possible in the second half of 2025 to resolve going concern issues[5] - The company will publish an announcement every three months from the date of this announcement until the disclaimer of opinion is resolved[5] - The company may also publish further announcements for any significant updates as appropriate[5] Other Information This section provides details on the Board of Directors and the disclaimer from Hong Kong Exchanges and Clearing Limited Board of Directors The Board of Directors includes five executive directors and two independent non-executive directors, as listed in this announcement - The Board of Directors includes executive directors Mr. Zhang Zhangsun, Ms. Ruan Wenjuan, Mr. Yang Huabin, Mr. Feng Yang, and Mr. Zhao Yuhong[6] - Independent non-executive directors include Ms. Chen Jinrong and Mr. Deng Zhidong[6] HKEX Disclaimer HKEX and The Stock Exchange of Hong Kong Limited disclaim responsibility for this announcement's content, accuracy, completeness, and any resulting losses - Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this announcement[1] - They make no representation as to its accuracy or completeness[1] - They expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the contents of this announcement[1]